학술논문

Preclinical Activity of JNJ-7957, a Novel BCMA ×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab
Document Type
Article
Source
In: Clinical Cancer Research. (Clinical Cancer Research, 1 May 2020, 26(9):2203-2215)
Subject
Language
English
ISSN
15573265
10780432